Moreover, inhibiting the Rho/ROCK signaling pathway in NSCLC using the ROCK inhibitor fasudil, when combined with inhibition of the proteasome, effectively reduced the viability of mutant K-Ras cells compared with wild-type cells.132. Here, KRAS is linked to non-small cell lung carcinoma.